Prevalence of anaemia and its clinical management in patients with stages 3-5 chronic kidney disease not on dialysis in cataloniad: MICENAS I study;Prevalencia de anemia y su manejo clínico en la enfermedad renal crónica estadios 3-5 no en diálisis en cataluña: Estudio MICENAS I

Nefrologia

Volumn 34, Issue 2, 2014, Pages 189-198

  Cases Amenós, Aleix ^a   Martínez Castelao, Alberto ^b   Fort Ros, Joan ^c   Bonal Bastons, Jordi ^d   Ruiz, M Pilar ^e   Vallés Prats, Martí ^f   Coll Piera, Elisabeth ^g   Galcerán Gui, Josep M ^h   Arias, M ^a   Perello M ^c   Samon, R ⁱ   Agraz, I ^c   Bayes, B ^d   Canas L ^d   Castellote, E ^j   Craver, L ^k   Garcia R ^l   Felip, A ^m   Lauzurica, R ^d   Pou, M ⁿ   Ballarin J ^g   Puig, J M ^o   Puig, C ^p   Cao, H ^o   Collado, S ^o   Barbosa, F ^o   Martinez Vea A ^q   more..

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e Moises Broggi Hospital Sant Joan d'Espì   (Spain)

^f HOSPITAL JOSEP TRUETA   (Spain)

^g FUNDACIÓ PUIGVERT   (Spain)

^h Althaia   (Spain)

ⁱ Hospital de Mollet   (Spain)

^j HOSPITAL GENERAL DE VIC   (Spain)

^k HOSPITAL ARNAU DE VILANOVA   (Spain)

^l Hospital Palamós   (Spain)

^m Hospital of Mataro   (Spain)

ⁿ Hospital Terrassa   (Spain)

^o HOSPITAL DEL MAR   (Spain)

^p Hospital d'Igualada   (Spain)

^q HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

more..

Author keywords

Anemia; Chronic kidney disease; Erythropoiesisstimulating agents; Iron deficiency

Indexed keywords

AGED; ANEMIA; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; SPAIN;

AGED; ANEMIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; SPAIN;

EID: 84897891372     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2013.Dec.12261     Document Type: Article

References (29)

1. Otero A, Gayoso P, Garcia F, de Francisco AL; EPIRCE study group. Epidemiology of chronic renal disease in the Galician Population: results of the pilot Spanish Epirce study. Kidney Int Suppl 2005;(99):S16-9.
2. US Renal Data System: USRDS 2009 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
3. Rucker D, Tonelli M. Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol 2009;5:287-96.
4. Kazmi WH, Kausz AT, Khan S, Abichandani R, Ruthazer R, Obrador GT, et al. Anemia: an early complication of chronic renal insufficiency. Am J Kidney Dis 2001;38:803-12.
5. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia. The Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002;162:1401-8.
6. Obrador GT, Roberts T, St Peter WL, Frazier E, Pereira BJG, Collins AJ. Trends in anemia at initiation of dialysis in the United States. Kidney Int 2001;60:1875-84.
7. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomiopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996;28:53-61.
8. Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, Jofre R, Valderrabano F. Increasing the hematocrit has beneficial effect on quality of life and is safe in selected haemodialysis patients. Spanish Cooperative Renal Patients Quality of life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol 2000;11:335-42.
9. Cody J, Daly C, Campbell M, Donaldson C, Khan I, Rabindranath K, et al. Recombinant human erythropoietin for chronic renal failure anemia in pre-dialysis patients. Cochrane Database Syst Rev 2005;(3):CD003266.
10. De Nicola L, Chiodini P, Zoccali C, Borrelli S, Cianciaruso B, Di Iorio B, et al.; SIN-TABLE CKD Study Group. Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clin J Am Soc Nephrol 2011;6:2421-8.
11. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al.; CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-98.
12. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, et al.; CREATE investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071-84.
13. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al.; TREAT investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009;361:2019-32.
14. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, et al. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 2010;153:23-33.
15. Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ. The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch Intern Med 2009;169:1104-12.
16. Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P. Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis. Clin J Am Soc Nephrol 2009;4:755-62.
17. Locatelli F, Aljama P, Canaud B, Covic A, De Francisco, Macdougall IC, et al.; Anemia Working group of European Best Practice (ERBP). Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) study. Nephrol Dial Transplant 2010;25:2846-50.
18. Ref. EMEA/188068/2007 European Medicines Agency starts review of the safety of epoetins. Available at: http://www.halmed.hr/upl/novosti/18806807en.pdf.
19. Martínez-Castelao A, Górriz JL, Portolés JM, De Alvaro F, Cases A, Luño J, et al. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. BMC Nephrol 2011;12:53.
20. De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, et al.; Target Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006;69:538-45.
21. Portolés J, Gorriz JL, Rubio E, de Alvaro F, García F, Alvarez-Chivas V, et al.; NADIR-3 Study Group. The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease. BMC Nephrol 2013;14:2.
22. Dikow R, Schwenger V, Schomig M, Ritz E. How should we manage anemia in patients with diabetes?. Nephrol Dial Transplant 2001;17:67-72.
23. Bosman DR, Winker AS, Marseden JT, MacDougall IC, Watkins PJ. Anaemia with erythropoietin deficiency occurs early in diabetic nephropaty. Diabetes Care 2001;24:495-9.
24. Agarwal AK, Silver MR, Reed JE, Dhingra RK, Liu W, Varma N, et al. An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis. J Intern Med 2006;260:577-85.
25. Minutolo R, Zamboli P, Chiodini P, Mascia S, Vitiello S, Stanzione G, et al. Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients. Blood Purif 2010;30:186-94.
26. Frimat L, Mariat C, Landais P, Koné S, Commenges B, Choukroun G. Anaemia management with C.E.R.A. in routine clinical practice: OCEANE (Cohorte Mircera patients non-dialyses), a national, multicenter, longitudinal, observational prospective study, in patients with chronic kidney disease not on dialysis. BMJ Open 2013;3(3):e001888. pii: e001888. doi: 10.1136/bmjopen- 2012-001888.
27. Cuevas X, García F, Martín-Malo A, Fort J, Lladós F, Lozano J, et al. Risk factors associated with cardiovascular morbidity and mortality in Spanish incident hemodialysis patients: two-year results from the ANSWER Study. Blood Purif 2011;33(1-3):21-9.
28. Besarab A, Coyne DW. Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol 2010;6:699-710.
29. KDIGO. Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl 2012;2:279-335.